[
  {
    "ts": null,
    "headline": "Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo",
    "summary": "Eli Lilly and Co. (NYSE:LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for plaque psoriasis and obesity. The study demonstrated the efficacy of its drugs Taltz and Zepbound in treating psoriasis and obesity. 27.1% of participants receiving Taltz and Zepbound reached complete skin clearance (Psoriasis Area Severity Index (PASI) 100) and at leas",
    "url": "https://finnhub.io/api/news?id=057ce5a2a415d82fae13996b910aed74362beccd6bd7abb01bb60741bc33a850",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771695061,
      "headline": "Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo",
      "id": 139171437,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Co. (NYSE:LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for plaque psoriasis and obesity. The study demonstrated the efficacy of its drugs Taltz and Zepbound in treating psoriasis and obesity. 27.1% of participants receiving Taltz and Zepbound reached complete skin clearance (Psoriasis Area Severity Index (PASI) 100) and at leas",
      "url": "https://finnhub.io/api/news?id=057ce5a2a415d82fae13996b910aed74362beccd6bd7abb01bb60741bc33a850"
    }
  },
  {
    "ts": null,
    "headline": "The Stock Market Just Did This for the First Time in Nearly a Year. History is Strikingly Clear About What Happens Next.",
    "summary": "Market gains have left some stocks trading at expensive levels.",
    "url": "https://finnhub.io/api/news?id=105f8ce4aa6865837988c38a7399bca89a45a046715c5e82f26e248774b4a2a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771666500,
      "headline": "The Stock Market Just Did This for the First Time in Nearly a Year. History is Strikingly Clear About What Happens Next.",
      "id": 139167791,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Market gains have left some stocks trading at expensive levels.",
      "url": "https://finnhub.io/api/news?id=105f8ce4aa6865837988c38a7399bca89a45a046715c5e82f26e248774b4a2a3"
    }
  },
  {
    "ts": null,
    "headline": "Our Top 10 High Growth Dividend Stocks - February 2026",
    "summary": "Our Top 10 High Growth Dividend Stocks - February 2026",
    "url": "https://finnhub.io/api/news?id=7e4b7ba1073332d4439dfc03d03f581b051e454eb4339ab99a99626f6a31ae24",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771661700,
      "headline": "Our Top 10 High Growth Dividend Stocks - February 2026",
      "id": 139169057,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7e4b7ba1073332d4439dfc03d03f581b051e454eb4339ab99a99626f6a31ae24"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Stock Investors Just Got Great News From Eli Lilly",
    "summary": "But it's good news for Eli Lilly, too.",
    "url": "https://finnhub.io/api/news?id=7632285fd4d2f40e9ecbfaf113c7c1ceaf65fedba48c6c6dfd6b75f356450ff8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771637700,
      "headline": "Novo Nordisk Stock Investors Just Got Great News From Eli Lilly",
      "id": 139164828,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "But it's good news for Eli Lilly, too.",
      "url": "https://finnhub.io/api/news?id=7632285fd4d2f40e9ecbfaf113c7c1ceaf65fedba48c6c6dfd6b75f356450ff8"
    }
  }
]